Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (BluePoint Laboratories)
FDA approved an original application for venlafaxine from BluePoint Laboratories (venlafaxine hydrochloride) under an Abbreviated New Drug A…
-
FDA approval · 2008-06-13FDA Approved: VENLAFAXINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's generic venlafaxine under an original ANDA (ANDA078627). The approval adds a generic option for treating m…
-
FDA approval · 2008-05-23FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-05-20FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride/paroxetine from Zydus Lifesciences Limited, authorizing a generic parox…
-
FDA approval · 2008-05-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Vertical Pharmaceuticals, LLC)
The FDA approved a generic venlafaxine hydrochloride product (Original Application) developed by Vertical Pharmaceuticals, LLC, for the trea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-03-16FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for buspirone hydrochloride (generic) from Oxford Pharmaceuticals, LLC.
-
FDA approval · 2008-03-13FDA Approved: PAROXETINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic paroxetine product (paroxetine hydrochloride hemihydrate) from Mylan Pharmaceuticals Inc. under an original ANDA.
-
FDA approval · 2008-02-28FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for alprazolam from Sandoz Inc, updating the regulatory status of the product.
-
FDA approval · 2008-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp. to market a generic paroxetine hydrochloride product (PAROXETINE HYDROCHLORIDE).
-
FDA approval · 2007-12-17FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Oxford Pharmaceuticals, LLC)
FDA approved Buspirone hydrochloride as a generic drug under an Original Application by Oxford Pharmaceuticals, LLC.
-
FDA approval · 2007-12-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-11-28FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc. under ANDA074312, granting regulatory clearan…
-
FDA approval · 2007-09-20FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) filed by Viatris Specialty LLC.
-
FDA approval · 2007-08-01FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The action pertai…
-
FDA approval · 2007-07-25FDA Approved: PAROXETINE — Original Application (NorthStar Rx LLC)
FDA approves NorthStar Rx LLC's original ANDA for paroxetine hydrochloride (generic paroxetine).
-
FDA approval · 2007-07-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc. The approval updates t…
-
FDA approval · 2007-07-11FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental ANDA for doxepin hydrochloride from Mylan Pharmaceuticals Inc., enabling a generic version of the drug to en…
-
FDA approval · 2007-06-26FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for doxepin hydrochloride from Lannett Company, Inc., authorizing changes to an already approved pro…
-
FDA approval · 2007-06-21FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis (Pfizer) to update the labeling with expanded o…
-
FDA approval · 2007-03-16FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for buspirone hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2007-03-07FDA Approved: PAROXETINE — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences Limited's original application for paroxetine hydrochloride tablets (generic paroxetine). This approval prov…
-
FDA approval · 2007-02-13FDA Approved: ALPRAZOLAM EXTENDED RELEASE — Original Application (Actavis Pharma, Inc.)
FDA approved a generic alprazolam extended-release tablet (Actavis) via Original Application, adding another market option for anxiety and p…
-
FDA approval · 2007-02-05FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for paroxetine hydrochloride as a generic product. Paroxetine is used to treat maj…
-
FDA approval · 2006-11-29FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lorazepam by Hikma Pharmaceuticals USA Inc., authorizing modifications under the supplement.
-
FDA approval · 2006-09-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.